Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Incyte Corporation
Incyte Corporation
Fred Hutchinson Cancer Center
Stanford University
Incyte Corporation
Incyte Corporation
Dana-Farber Cancer Institute
Incyte Corporation
Prelude Therapeutics
City of Hope Medical Center
Incyte Corporation
Incyte Corporation
M.D. Anderson Cancer Center
Mayo Clinic
Washington University School of Medicine
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Brigham and Women's Hospital
University of Chicago
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Massachusetts General Hospital
Janssen Research & Development, LLC
Eli Lilly and Company
Cellenkos, Inc.
AbbVie
Northwestern University
Case Comprehensive Cancer Center
Astex Pharmaceuticals, Inc.
University of Chicago
Pfizer
Fox Chase Cancer Center
Columbia University
Ipsen
OHSU Knight Cancer Institute
Prelude Therapeutics
Perseus Proteomics Inc.
Herlev Hospital
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Taiga Biotechnologies, Inc.
Guizhou Bailing Group Pharmaceutical Co Ltd
Medigene AG
National Cancer Institute (NCI)
Novartis
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.